Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.422, 2003-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Memantine improves outlook, cuts healthcare costs in AD
Inpharma, Vol. 1, Iss. 1397, 2003-01 ,pp. :
Memantine cuts costs of AD for patients, caregivers
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :
Memantine cuts costs of AD for patients, caregivers
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. :
Rivastigmine slows AD and cuts costs
Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. :
Rivastigmine slows AD and cuts costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. :